Members of Arkansas' medical marijuana industry at a legislative subcommittee meeting last week aired frustrations with the state contractor used to track cannabis products and sales.
The vice chairwoman of the Arkansas Legislative Council's Medical Marijuana Oversight Subcommittee, Sen. Linda Chesterfield, D-Little Rock, raised the issue on Thursday, saying she had heard concerns about the accuracy of data in the Biotrack system and that the company had not been responsive to providers' needs.
The state, through the Arkansas Department of Health, signed a $560,000 contract with Biotrack in 2017, which can be renewed annually through 2024.